Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

NCT00002759 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Drug/Agent Toxicity by Tissue/Organ
Lymphoma
Neutropenia
Small Intestine Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: cyclosporine
DRUG: irinotecan hydrochloride
DRUG: phenobarbital

Sponsor

National Cancer Institute (NCI)